Cite

HARVARD Citation

    Young, C. et al. (2019). 177 Updated safety analysis of ocrelizumab in multiple sclerosis. Journal of neurology, neurosurgery and psychiatry. 90 (12), p. e47. [Online]. 
  
Back to record